196 related articles for article (PubMed ID: 15113037)
1. Antisense therapy specific to mutated K-ras gene in hamster pancreatic cancer model. Can it inhibit the growth of 5-FU and MMC-resistant metastatic and remetastatic cell lines?
Morioka CY; Saito S; Machado MC; Ohzawa K; Kubrusly MS; Cunha JE; Watanabe A
In Vivo; 2004; 18(2):113-7. PubMed ID: 15113037
[TBL] [Abstract][Full Text] [Related]
2. Suppression of invasion of a hamster pancreatic cancer cell line by antisense oligonucleotides mutation-matched to K-ras gene.
Morioka CY; Machado MC; Saito S; Nakada Y; Matheus AS; Jukemura J; Bacchella T; Takahara T; Watanabe A
In Vivo; 2005; 19(3):535-8. PubMed ID: 15875772
[TBL] [Abstract][Full Text] [Related]
3. Different pattern of metastasis in liver implanted pancreatic cancer between young and old Syrian golden hamsters.
Morioka CY; Saito S; Machado MC; Jukemura J; Bacchella T; Watanabe A
In Vivo; 2005; 19(3):639-41. PubMed ID: 15875787
[TBL] [Abstract][Full Text] [Related]
4. Interferon-alpha and antisense K-ras RNA combination gene therapy against pancreatic cancer.
Hatanaka K; Suzuki K; Miura Y; Yoshida K; Ohnami S; Kitade Y; Yoshida T; Aoki K
J Gene Med; 2004 Oct; 6(10):1139-48. PubMed ID: 15452878
[TBL] [Abstract][Full Text] [Related]
5. [The study of the effect of antisense oligonucleotide specific to K-ras point mutation on human pancreatic carcinoma cell PC-2].
Wang YX; Gao L; Ji ZZ
Zhonghua Wai Ke Za Zhi; 2005 Nov; 43(21):1387-90. PubMed ID: 16318775
[TBL] [Abstract][Full Text] [Related]
6. Subcutaneously inoculated cells and implanted pancreatic cancer tissue show different patterns of metastases in Syrian golden hamsters.
Morioka CY; Saito S; Ohzawa K; Asano S; Hibino Y; Nakada Y; Kita KI; Watanabe A
JOP; 2000 Nov; 1(4):183-90. PubMed ID: 11856860
[TBL] [Abstract][Full Text] [Related]
7. Identification of genes showing differential expression in antisense K-ras-transduced pancreatic cancer cells with suppressed tumorigenicity.
Ohnami S; Matsumoto N; Nakano M; Aoki K; Nagasaki K; Sugimura T; Terada M; Yoshida T
Cancer Res; 1999 Nov; 59(21):5565-71. PubMed ID: 10554036
[TBL] [Abstract][Full Text] [Related]
8. Comparison of metastatic behavior of parental and metastatic pancreatic cancer cell lines in Syrian golden hamsters.
Morioka CY; Saito S; Machado MC; Ohzawa K; Yamago GI; Bacchella T; Watanabe A
In Vivo; 2004; 18(1):63-6. PubMed ID: 15011753
[TBL] [Abstract][Full Text] [Related]
9. Suppression of colorectal cancer growth using an adenovirus vector expressing an antisense K-ras RNA.
Nakano M; Aoki K; Matsumoto N; Ohnami S; Hatanaka K; Hibi T; Terada M; Yoshida T
Mol Ther; 2001 Apr; 3(4):491-9. PubMed ID: 11319909
[TBL] [Abstract][Full Text] [Related]
10. Liver metastasis models of colon cancer for evaluation of drug efficacy using NOD/Shi-scid IL2Rgammanull (NOG) mice.
Hamada K; Monnai M; Kawai K; Nishime C; Kito C; Miyazaki N; Ohnishi Y; Nakamura M; Suemizu H
Int J Oncol; 2008 Jan; 32(1):153-9. PubMed ID: 18097554
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of oncolytic reovirus against liver metastasis from pancreatic cancer in immunocompetent models.
Himeno Y; Etoh T; Matsumoto T; Ohta M; Nishizono A; Kitano S
Int J Oncol; 2005 Oct; 27(4):901-6. PubMed ID: 16142304
[TBL] [Abstract][Full Text] [Related]
12. "Return trip" metastases from the liver to the pancreas in Syrian golden hamsters.
Morioka CY; Saito S; Watanabe A
In Vivo; 2000; 14(3):467-9. PubMed ID: 10904884
[TBL] [Abstract][Full Text] [Related]
13. Pharmacologic inactivation of kinase suppressor of ras-1 abrogates Ras-mediated pancreatic cancer.
Xing HR; Cordon-Cardo C; Deng X; Tong W; Campodonico L; Fuks Z; Kolesnick R
Nat Med; 2003 Oct; 9(10):1266-8. PubMed ID: 12960962
[TBL] [Abstract][Full Text] [Related]
14. Suppression of Ki-ras p21 levels leading to growth inhibition of pancreatic cancer cell lines with Ki-ras mutation but not those without Ki-ras mutation.
Aoki K; Yoshida T; Matsumoto N; Ide H; Sugimura T; Terada M
Mol Carcinog; 1997 Oct; 20(2):251-8. PubMed ID: 9364215
[TBL] [Abstract][Full Text] [Related]
15. Intraperitoneal injection of adenovirus expressing antisense K-ras RNA suppresses peritoneal dissemination of hamster syngeneic pancreatic cancer without systemic toxicity.
Miura Y; Ohnami S; Yoshida K; Ohashi M; Nakano M; Ohnami S; Fukuhara M; Yanagi K; Matsushita A; Uchida E; Asaka M; Yoshida T; Aoki K
Cancer Lett; 2005 Jan; 218(1):53-62. PubMed ID: 15639340
[TBL] [Abstract][Full Text] [Related]
16. A clinical nude mouse metastatic model for highly malignant human pancreatic cancer.
An Z; Wang X; Kubota T; Moossa AR; Hoffman RM
Anticancer Res; 1996; 16(2):627-31. PubMed ID: 8687107
[TBL] [Abstract][Full Text] [Related]
17. Inhibitary effects of antisense oligonucleotide specific to K-ras point mutation on the target gene expression in human pancreatic carcinoma cells.
Wang YX; Gao L; Ji ZZ
Chin Med J (Engl); 2007 Aug; 120(16):1448-50. PubMed ID: 17825176
[No Abstract] [Full Text] [Related]
18. Bcl-XL antisense oligonucleotides coupled with antennapedia enhances radiation-induced apoptosis in pancreatic cancer.
Masui T; Hosotani R; Ito D; Kami K; Koizumi M; Mori T; Toyoda E; Nakajima S; Miyamoto Y; Fujimoto K; Doi R
Surgery; 2006 Aug; 140(2):149-60. PubMed ID: 16904964
[TBL] [Abstract][Full Text] [Related]
19. Retinoic acid receptor antagonists inhibit miR-10a expression and block metastatic behavior of pancreatic cancer.
Weiss FU; Marques IJ; Woltering JM; Vlecken DH; Aghdassi A; Partecke LI; Heidecke CD; Lerch MM; Bagowski CP
Gastroenterology; 2009 Dec; 137(6):2136-45.e1-7. PubMed ID: 19747919
[TBL] [Abstract][Full Text] [Related]
20. Molecular consequences of silencing mutant K-ras in pancreatic cancer cells: justification for K-ras-directed therapy.
Fleming JB; Shen GL; Holloway SE; Davis M; Brekken RA
Mol Cancer Res; 2005 Jul; 3(7):413-23. PubMed ID: 16046552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
